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According to the recent developments of Cu(I)-catalyzed 
azide-alkyne 1,3-dipolar cycloaddition (CuAAC) as the most 
useful ligation process in click chemistry,1,2 a variety of 
compounds with 1,4-disubstituted 1,2,3-triazole backbone have 
been synthesized.3 The 1,2,3-triazole linkage has been revealed to 
be a promising amide bond surrogate, particularly with respect to 
its structure and hydrogen-bonding ability, while it shows a 
higher chemical and biological stability in comparison with the 
amide bonds.4 Thus, it is now of great interest to elucidate the 
effects of replacement of an amide bond with a 1,2,3-triazole ring 
on the secondary structure as well as on the bioactivities in a 
wide range of amides. Recently, Angelo and Arora introduced a 
new class of oligotriazole as a peptidomimetic, named 
tirazolamer, in which the triazole rings and the sp3-hybridized 
carbons possessing amino acid side chains are alternately 
connected. They indicated that optically active trimeric and 
tetrameric triazolamers adopt zigzag conformations and show a 
potential inhibitory activity of HIV-1 protease.5 
Their synthetic method for preparation of triazolamer employs 
N-Boc propargylamines derived from amino acids as a synthetic 
component and involves a three-step iterative reaction sequence; 
diazotransfer to amines, CuAAC reaction of the resulting azides 
with N-Boc propargylamines, followed by deprotection of the 
amines.5a On the other hand, Hughes and co-workers described a 
more convenient synthesis of triazolamers employing propargyl 
azide possessing a trialkylsilyl group at the acetylenic terminal.6 
Since the silyl group prevents the propargyl azides from self-
polymerization by CuAAC reaction, extension of a triazolic 
chain can be attained by a two-step iterative reaction sequence 
involving CuAAC reaction and desilylation. In this letter, we 
wish to report a new approach to the synthesis of triazolamers 
utilizing a dicobalt hexacarbonyl complex of propargyl azides 



















Alkynes are known to readily react with dicobalt octacarbonyl 
by simple mixing to the formation of alkyne–dicobalt 
hexacarbonyl complex, which can undergo oxidative degradation 
to liberate the alkynes.7 Thus, if the alkyne–cobalt complexes are 
inert to CuAAC, chain extension of triazolamers can be 
accomplished by only a repetition of CuAAC and oxidative 
deprotection of alkynes. Variety of CPAs can be readily prepared 
from not only propargyl azide with dicobalt octacarbonyl, but 
also propargyl alcohols or alk-3-en-1-yne compounds by 
Nicholas reaction via the alkyne–cobalt complexes.7,8 
We employed several types of CPA possessing a substituent 
(R) corresponding to the side chain of the natural amino acids. As 
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We have developed an efficient method for preparation of triazolamers using a dicobalt
hexacarbonyl complex of propargyl azides (CPA) as a synthetic component. Several types of 
CPAs possessing the side chains (R) found in the natural amino acids were prepared by Nicholas
reaction as well as by a reaction of propargyl azides with dicobalt octacarbonyl. Triazolamers 
with both amino and carboxyl termini were readily synthesized by repetitive reaction sequence
involving a copper-catalyzed 1,3-dipolar cycloaddition followed by an oxidative deprotection. 
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we had expected, CPAs (2a–f) were readily prepared from the 
corresponding propargyl alcohols (1a–f) by Nicholas reaction 
using TMSN3 and BF3-Et2O (Table 1).9 Since 2g (R = 
CH2CH2SMe) possessing the side chain of methionine was found 
to be difficult to synthesize by the same method presumably due 
to the high nucleophilicity of sulfide group, it was prepared in a 
stepwise fashion from 1g in 61%; mesylation of the hydroxyl 
group 1g, nuculeophilic substitution with sodium azide, followed 
by complexation with Co2(CO)8 (Eq 1). 
 
 






1) CO2(CO)8 (1.2 eq)
2) BF3-OEt2 (1.1 eq), 
    TMSN3 (2.0 eq)1a–f CPA: 2a–fCH2Cl2, 0°C
CH2Cl2, rt, 2 h
 
CPA (2) R Reaction timea Yield %b 
2a H 10 h 81 
2b Me 6 h 78 
2c i-Bu 3 h 88 
2d Bn 16 h 79 
2e CH2OAc 8 h 71 
2f CH2CH2COOMe 5 h 86 
aThe reaction time of the second step.  







1) MsCl, Et3N, CH2Cl2
2) NaN3, DMSO




61% yield (3 steps)  
Eq 1 
 
We designed triazolamers possessing both amino and carboxyl 
groups on their termini to mimic the structure of peptide chains 
(Scheme 1). The CuAAC reaction between 2a and N-
benzoylpropargylamine 3 was attempted under several conditions 
according to literatures,2b,10 and the best yield of 4a was obtained 
by using CuSO4 and sodium L-ascorbate in a heterogeneous 
mixed solvent of dichloromethane and water (1 : 1).10a The crude 
reaction mixture obtained by CuAAC was directly treated with 
ceric ammonium nitrate (CAN) for deprotection of the alkyne 
followed by purification by column chromatography to give the 
corresponding monotriazole 4a in 76% yield.11 The second 
reaction cycle was carried out on the resulting 4a using various 
types of CPA 2a–g under the same conditions, and bis(triazoles) 
5 with various substituents were obtained in reasonable yields. 
The final elongation of 5 with methyl azidoacetate 6 gave 
tris(triazoles) 7 in good yields. 
Epimerization at the asymmetric -carbon of the carbonyl 
groups of peptide bonds has been a major challenge in peptide 
synthesis, as seen in its history. Thus, it is essential to employ 
synthetic methods free form racemization at the-carbon in 
preparation of peptides. Since the same thing holds true for 
preparation of chiral triazolamers, we examined the possibility 
that our synthetic method is accompanied by epimerization at the 
asymmetric -carbon between two triazoles and/or at the 
propargyl carbon of CPA. As shown in Scheme 2, by using (S)-
2d,12,13 whose enantiomeric purity was 92% ee, we synthesized 
triazole 4d and bis(triazole) 8 in 79% and 75% yield, respectively. 
Both of them exhibited exactly the same enantiomeric purity as 
2d (92% ee), indicating that no epimerization took place during a 





1) 2a (1.1 equiv)
    CuSO4-5H2O
    Sodium L-ascorbate







1) 2a–g (1.1 equiv)
    CuSO4-5H2O
    Sodium L-ascorbate










5a: R = H (67%)
5b: R = Me (68%)
5c: R = i-Bu (76%)
5d: R = Bn (75%)
5e: R = CH2OAc (66%)
5f: R = CH2CH2COOMe (70%)
5g: R = CH2CH2SMe (72%)
CuSO4-5H2O
Sodium L-ascorbate












7a: R = H (72%)
7b: R = Me (78%)
7c: R = i-Bu (86%)
7d: R = Bn (90%)
7e: R = CH2OAc (69%)
7f: R = CH2CH2COOMe (82%)










3) TfN3, CuSO4, K2CO3
    CH2Cl2/MeOH/H2O N3
Co2(CO)6







    CuSO4-5H2O
    Sodium L-ascorbate











    CuSO4-5H2O
    Sodium L-ascorbate















In conclusion, we have demonstrated a new strategy for the 
synthesis of triazolamer using CPAs 2 as a monomeric synthetic 
component. The cobalt complex has two different roles in our 
method; one is the protection of alkynes, and the other is the 
essential activating group for Nicholas reaction to prepare CPAs, 
in part. The chain extension of triazolamer is conveniently 
attained without racemization by iteration of reaction sequence of 
CuAAC and oxidative deprotection. Further applications of our 
method for preparation of various oligotriazoles are currently 
under investigation. 
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